Dr. Wolfgang Andiel, president of the Austrian Association of Generic Medicines (OeGV, Österreichischer Generikaverband), which acts as a unified voice to represent generics companies in Austria, provides an in-depth analysis of the vicious cycle associated with establishing generics market share in Austria as well as the inconsistences of government regulations in this sector. He also gives insights into the strategies being employed to incite change and the how the potential of hosting the EMA will influence the Austrian healthcare ecosystem.
As the President at OeGV, could you please introduce the association to our international readers?
"In pharmaceutical manufacturing and innovation Austria contains world-leading and local companies such as Sandoz, Fresenius,GL Pharma and Genericon, which create indirect and direct employment opportunities."
